Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
WBC-AMD-01
- Development stage
- Preclinical
- Lead developer
- Wincal Biopharm
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics
- Administration
- Ophthalmic
01
Overview
WBC-AMD-01 is an investigational therapeutic candidate developed by Wincal Biopharm for the treatment of age-related macular degeneration (AMD). It is designed to inhibit pathological angiogenesis through a dual-action mechanism targeting both Vascular Endothelial Growth Factor (VEGF) and Frizzled (FZD) receptors. By simultaneously blocking the VEGF pathway and the Wnt/Frizzled signaling pathway, WBC-AMD-01 aims to provide enhanced efficacy and improved vascular stability compared to existing anti-VEGF monotherapies. The program is currently in the IND-enabling stage, progressing toward clinical trials for ophthalmic vascular diseases.
02
Targets
PGF (Placental Growth Factor)VEGFA (Vascular endothelial growth factor A)
Beyond the preview
Go deeper on WBC-AMD-01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on WBC-AMD-01.